Barclays PLC Grifols Sa Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Grifols Sa stock. As of the latest transaction made, Barclays PLC holds 83,418 shares of GRFS stock, worth $621,464. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83,418
Previous 592,552
85.92%
Holding current value
$621,464
Previous $5.26 Million
88.2%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding GRFS
# of Institutions
169Shares Held
145MCall Options Held
166KPut Options Held
103K-
Capital World Investors Los Angeles, CA21.1MShares$157 Million0.02% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA20.5MShares$153 Million1.82% of portfolio
-
Permian Investment Partners, LP New York, NY16.2MShares$121 Million21.69% of portfolio
-
Black Creek Investment Management Inc. Toronto, A611.3MShares$83.8 Million3.99% of portfolio
-
Armistice Capital, LLC New York, NY10MShares$74.8 Million1.05% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $5.06B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...